[VIR] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[VIR] Vir Biotechnology, Inc.
Announcement Date
04-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -54.44%
YoY- -30.78%
Quarter Report
VIR's Result
VIR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 2,380 3,075 56,376 16,787 -4,098 -12,722 46,712 -86.18%
PBT -213,540 -139,890 -65,000 -120,757 -166,626 -197,623 -143,188 30.43%
Tax 177 -1,512 276 -4,784 -3,213 -2,848 -2,232 -
NP -213,717 -138,378 -65,276 -115,973 -163,413 -194,775 -140,956 31.87%
Tax Rate - - - - - - - -
Total Cost 216,097 141,453 121,652 132,760 159,315 182,053 187,668 9.83%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -8,979.71 -4,500.10 -115.79 -690.85 3,987.63 1,531.01 -301.76 854.36%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -1.56 -1.02 -0.48 -0.86 -1.22 -1.45 -1.06 29.29%
EPS Diluted -1.56 -1.02 -0.48 -0.86 -1.22 -1.45 -1.06 29.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.